Skip to content

Effect of butorphanol on effective volume and anesthetic effect of ropivacaine in axillary brachial plexus block

Effect of butorphanol on effective volume and anesthetic effect of ropivacaine in axillary brachial plexus block

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077132
Enrollment
Unknown
Registered
2023-10-31
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper limb injury

Interventions

Adjuvant group:0.3% ropivacaine after compound butorphanol (1mg)

Sponsors

Kunming Yan'an Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: The age was 18-70 years old, BMI 18.5-27.9 graded by I-III, and the time of hand operation was 0.5-6h. There was no infection or tumor at the puncture site, no abnormal blood coagulation function, no mental abnormality of mental menstruation, no history of anesthetic allergy, and normal heart, lung, liver and kidney function. The patients who need to complete the operation under axillary brachial plexus block were studied.

Exclusion criteria

Exclusion criteria: (1) patients refuse to perform brachial plexus block anesthesia; (2) potential risk of increased intracranial pressure; (3)uncontrolled or poorly controlled high blood pressure; (4)opioids lasting more than 10 days a day; (5) patients who are participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Onset time of sensory block;Onset time of motor block;Duration of sensory block;Duration of motor block;Evaluation standard of brachial plexus block effect;

Secondary

MeasureTime frame
VAS score ;Evaluation of recovery quality of patients;Incidence of postoperative rebound pain;Incidence of tourniquet pain;

Countries

China

Contacts

Public ContactWANG Xiaoting

Kunming Yan'an Hospital

1269130123@qq.com+86 182 8748 1997

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026